17 results
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
18 Jun 24
Entry into a Material Definitive Agreement
8:36am
/NSCLC mPFS: 1.5-2.9m for Ovarian (Pt-resistant)/TNBC/NSCLC MMAE program limited by toxicity, resulting in reduced dose intensity and duration A next
10-K
e0ehykf
7 Mar 22
Annual report
7:36am
10-Q
35wjkd38
10 Aug 21
Quarterly report
5:26pm
424B4
139bkpn9u rqo7nm4w
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
z90rtn7q k090
24 May 21
IPO registration (amended)
6:16am
S-1
0ms4t khym5f1h
4 May 21
IPO registration
4:12pm
DRS
myw6323siw0
19 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next